These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
89 related items for PubMed ID: 5056113
21. The action of BC-105 in chronic schizophrenics with depression. Krumholz WV, Yaryura-Tobias JA, White L. Curr Ther Res Clin Exp; 1968 Jul; 10(7):342-4. PubMed ID: 4174127 [No Abstract] [Full Text] [Related]
23. Collaborative care and motivational interviewing: improving depression outcomes through patient empowerment interventions. Anderson B. Am J Manag Care; 2007 Nov 01; 13(4 Suppl):S103-6. PubMed ID: 18041866 [Abstract] [Full Text] [Related]
24. The management of anxious depression in primary care. Goldberg D. J Clin Psychiatry; 1999 Nov 01; 60 Suppl 7():39-42; discussion 43-4. PubMed ID: 10326873 [Abstract] [Full Text] [Related]
25. Acute phenothiazine dystonia. Gillis A. Lancet; 1969 Dec 13; 2(7633):1299-300. PubMed ID: 4188001 [No Abstract] [Full Text] [Related]
26. Correlation between electroencephalographic deviations following anti-psychotic drug treatment and the course of mental illness. Dasberg H, Robinson S. Isr Ann Psychiatr Relat Discip; 1969 Nov 13; 7(2):185-200. PubMed ID: 5274357 [No Abstract] [Full Text] [Related]
27. New federal guidelines seek to help primary care providers recognize and treat depression. Agency for Health Care Policy and Research (AHCPR) of the Department of Human Services. Hosp Community Psychiatry; 1993 Jun 13; 44(6):598. PubMed ID: 8514318 [No Abstract] [Full Text] [Related]
28. [Consideration of Sasagawa Optimal Treatment Project--comprehensive community mental health care]. Sakuma H. Seishin Shinkeigaku Zasshi; 2009 Jun 13; 111(3):324-9. PubMed ID: 19499644 [No Abstract] [Full Text] [Related]
29. [Retard neuroleptics and community assistance in schizophrenia]. Mezquita J, Gonzalez Roa G, Urrexola DM. Arch Neurobiol (Madr); 1975 Jun 13; 38(5):455-70. PubMed ID: 1227425 [No Abstract] [Full Text] [Related]
30. [On the clinical testing of doxepin, a new type of antidepressive-acting substance]. Bergener M, Behrends K. Arzneimittelforschung; 1966 Dec 13; 16(12):1617-20. PubMed ID: 6014795 [No Abstract] [Full Text] [Related]
31. [Trial of G 34-586 perfusions in 43 patients]. Margat P, Broussot T. Ann Med Psychol (Paris); 1969 Mar 13; 1(3):461-8. PubMed ID: 5376739 [No Abstract] [Full Text] [Related]
32. [Considerations on the therapeutic management of mixed psychoses and of depressive manifestations symptomatic of schizophrenia]. Scala A. Osp Psichiatr; 1967 Mar 13; 35(4):501-34. PubMed ID: 5607254 [No Abstract] [Full Text] [Related]
33. [Antiparkinson drugs in neuroleptic treatment: comparative study of progressive and abrupt withdrawal]. Ben Hadj Ali B, Dogui M, Ben Ammou S, Lôo H. Encephale; 1995 Mar 13; 21(3):209-15. PubMed ID: 7649071 [Abstract] [Full Text] [Related]
34. [Drug therapy and psychotherapy of depression]. Grabowski JR. J Bras Psiquiatr; 1969 Mar 13; 18(3):247-54. PubMed ID: 5407001 [No Abstract] [Full Text] [Related]